{"nct_id":"NCT02094573","title":"A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib","status":"COMPLETED","status_verified_date":"2021-02","start_date":"2014-06-04","start_date_type":"ACTUAL","primary_completion_date":"2016-02-29","primary_completion_date_type":"ACTUAL","completion_date":"2020-02-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["TAK"]}